HLA-matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening

被引:17
|
作者
Kreuger, Aukje L. [1 ,2 ]
Makelburg, Anja B. U. [3 ,4 ]
Somers, Judith A. E. [3 ,5 ]
Tomson, Bert [3 ]
van de Watering, Leo M. G. [3 ]
van der Bom, Johanna G. [1 ,2 ]
van Kraaij, Marian G. J. [1 ,3 ,6 ]
Weller, Claudia M. [3 ]
机构
[1] Sanquin Res, Ctr Clin Transfus Res, Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
[3] Sanquin Blood Bank, Unit Transfus Med, Amsterdam, Netherlands
[4] Sanquin Blood Bank, Unit Donor Affairs, Amsterdam, Netherlands
[5] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands
[6] Erasmus MC Daniel Den Hoed Canc Ctr, Dept Hematol, Rotterdam, Netherlands
关键词
THROMBOCYTOPENIA; MANAGEMENT; INCREMENTS;
D O I
10.1111/trf.15530
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Recipients of platelet transfusions with 1-hour corrected count increments (1hCCIs) of 7.5 or less on two subsequent platelet transfusions with random platelets may benefit from human leukocyte antigen (HLA)-matched platelet concentrates. We aimed to quantify the efficacy of HLA-matched platelets concentrates expressed in 1hCCIs. METHODS We performed a cohort study among consecutive refractory patients who received HLA-matched platelet concentrates in the Netherlands between 1994 and 2017. We performed mixed-model linear regression comparing 1hCCIs after HLA split-antigen-matched transfusions with 1hCCIs after HLA-mismatched transfusions, adjusted for within-patient correlations. A donor-to-patient match was categorized as a split-match if all donor HLA-A and -B antigens were present in the patient as well; that is, donor and patient were HLA identical or compatible. Subgroup analyses were performed for patients with positive or negative HLA antibody screens. Finally, the additional effect of ABO mismatches on 1hCCIs was investigated. RESULTS The 1hCCI after an HLA-matched transfusion was 14.09 (95% reference interval, 1.13-29.89). This was 1.94 (95% confidence interval [CI], 0.74-3.15) higher than 1hCCI after HLA-mismatched transfusions. In patients with negative HLA antibody screening tests, HLA matching did not affect 1hCCIs. Conditional on HLA matching, 1hCCIs decreased by 3.70 (95% CI, -5.22 to -2.18) with major ABO mismatches. CONCLUSION Matched platelet concentrates yielded maximal 1hCCIs, whereas mismatched transfusions still resulted in adequate increments. There is no indication for HLA-matched platelets in patients with negative antibody screens.
引用
收藏
页码:3303 / 3307
页数:5
相关论文
共 50 条
  • [41] HLA-ANTIGEN MATCHED PLATELET AND GRANULOCYTE TRANSFUSIONS FOR PATIENTS WITH LEUKEMIA AND APLASTIC-ANEMIA
    DAVEY, MG
    WRIGHT, D
    JAMES, J
    PATHOLOGY, 1979, 11 (02) : 306 - 306
  • [42] MEASLES ANTIBODY-TITERS IN MULTIPLE-SCLEROSIS PATIENTS AND HLA-MATCHED AND UNMATCHED SIBLINGS
    VISSCHER, BR
    SULLIVAN, CB
    DETELS, R
    MADDEN, DL
    SEVER, JL
    TERASAKI, PI
    PARK, MS
    DUDLEY, JP
    NEUROLOGY, 1981, 31 (09) : 1142 - 1145
  • [43] The clinical spectrum of HLA-matched platelet transfusion support in a large Transfusion Service
    Lopez-Plaza, I
    Dean, D
    Simpson, M
    Kiss, J
    TRANSFUSION, 2001, 41 (09) : 10S - 10S
  • [44] A NEW PLATELET-SPECIFIC ANTIGEN, NAKA, INVOLVED IN THE REFRACTORINESS OF HLA-MATCHED PLATELET TRANSFUSION
    IKEDA, H
    MITANI, T
    OHNUMA, M
    HAGA, H
    OHTZUKA, S
    KATO, T
    NAKASE, T
    SEKIGUCHI, S
    VOX SANGUINIS, 1989, 57 (03) : 213 - 217
  • [45] Ensuring HLA-matched platelet support requires an ethnic diverse donor population
    Kreuger, Aukje L.
    Haasnoot, Geert W.
    Somers, Judith A. E.
    Tomson, Bert
    van der Bon, Johanna G.
    van Kraaij, Marian G. J.
    Weller, Claudia M.
    TRANSFUSION, 2020, 60 (05) : 940 - 946
  • [46] Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions
    Brooks, Erin G.
    MacPherson, Bruce R.
    Fung, Mark K.
    TRANSFUSION, 2008, 48 (10) : 2159 - 2166
  • [47] Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions
    Brooks, Erin G.
    MacPherson, Bruce R.
    Fung, Mark K.
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S136 - S136
  • [48] Selecting platelet donors for refractory patients using HLA antibody specificity.
    Petz, LD
    Garratty, G
    Calhoun, L
    Cecka, M
    Clark, BD
    Gresens, C
    Gornbein, JA
    Landaw, EM
    Smith, R
    Terasaki, PI
    TRANSFUSION, 1999, 39 (10) : 44S - 44S
  • [49] Retrospective Analysis for 138 HLA-seleced Platelet Transfusions for Immune-mediated Platelet Refractory Patients
    Liu, Ying
    Xu, Xianguo
    He, Ji
    Zhu, Faming
    Hu, Wei
    TRANSFUSION, 2021, 61 : 191A - 192A
  • [50] CLINICAL USEFULNESS OF HLA-ANTIBODY ANALYSIS OF ALLOIMMUNIZED THROMBOCYTOPENIC PATIENTS REQUIRING PLATELET TRANSFUSIONS
    MARRARI, M
    ORAL, A
    DUQUESNOY, RJ
    HUMAN IMMUNOLOGY, 1986, 17 (02) : 203 - 204